 Jeffrey Brent
Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Poisoning | 19 | 2025 | 111 | 3.730 |
Why?
| | Toxicology | 13 | 2025 | 41 | 2.610 |
Why?
| | Drug Overdose | 21 | 2025 | 319 | 2.570 |
Why?
| | Registries | 30 | 2025 | 1873 | 1.970 |
Why?
| | Analgesics, Opioid | 17 | 2025 | 886 | 1.360 |
Why?
| | Emergency Service, Hospital | 19 | 2025 | 1896 | 1.110 |
Why?
| | Decontamination | 2 | 2014 | 24 | 0.860 |
Why?
| | Burns, Chemical | 2 | 2014 | 28 | 0.860 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 7 | 2018 | 251 | 0.830 |
Why?
| | Snake Bites | 5 | 2022 | 28 | 0.830 |
Why?
| | Mesothelioma | 1 | 2023 | 38 | 0.820 |
Why?
| | Butterflies | 1 | 2023 | 22 | 0.810 |
Why?
| | Moths | 1 | 2023 | 38 | 0.800 |
Why?
| | Fentanyl | 6 | 2024 | 76 | 0.770 |
Why?
| | Methanol | 1 | 2021 | 34 | 0.750 |
Why?
| | Poisons | 1 | 2021 | 20 | 0.740 |
Why?
| | Acidosis | 1 | 2022 | 88 | 0.720 |
Why?
| | Abortion, Induced | 1 | 2022 | 101 | 0.680 |
Why?
| | Cobalt | 2 | 2017 | 51 | 0.670 |
Why?
| | Hip Prosthesis | 2 | 2017 | 36 | 0.670 |
Why?
| | Antidotes | 5 | 2023 | 136 | 0.650 |
Why?
| | Skin | 2 | 2014 | 711 | 0.620 |
Why?
| | Metformin | 1 | 2022 | 312 | 0.590 |
Why?
| | Arthroplasty, Replacement, Hip | 2 | 2017 | 135 | 0.580 |
Why?
| | Metal-on-Metal Joint Prostheses | 1 | 2017 | 2 | 0.580 |
Why?
| | Chromium | 1 | 2017 | 13 | 0.570 |
Why?
| | Hypoglycemia | 1 | 2022 | 425 | 0.550 |
Why?
| | Tramadol | 3 | 2024 | 10 | 0.530 |
Why?
| | Ethylene Glycol | 2 | 2021 | 13 | 0.530 |
Why?
| | Referral and Consultation | 8 | 2025 | 724 | 0.520 |
Why?
| | United States | 28 | 2025 | 13785 | 0.520 |
Why?
| | Chelating Agents | 3 | 2021 | 66 | 0.500 |
Why?
| | Chelation Therapy | 2 | 2013 | 11 | 0.470 |
Why?
| | Humans | 66 | 2025 | 128020 | 0.440 |
Why?
| | Mercury Poisoning, Nervous System | 1 | 2013 | 3 | 0.440 |
Why?
| | Diabetes Mellitus | 1 | 2022 | 994 | 0.430 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2013 | 61 | 0.420 |
Why?
| | Inappropriate Prescribing | 1 | 2013 | 52 | 0.420 |
Why?
| | Pyrazoles | 2 | 2021 | 401 | 0.420 |
Why?
| | Decision Support Techniques | 1 | 2017 | 396 | 0.410 |
Why?
| | Middle Aged | 31 | 2025 | 30813 | 0.410 |
Why?
| | Benzodiazepines | 2 | 2025 | 130 | 0.400 |
Why?
| | Antivenins | 4 | 2022 | 35 | 0.380 |
Why?
| | Prospective Studies | 18 | 2025 | 7035 | 0.380 |
Why?
| | Paraquat | 1 | 2011 | 15 | 0.380 |
Why?
| | Herbicides | 1 | 2011 | 22 | 0.370 |
Why?
| | Young Adult | 22 | 2025 | 12282 | 0.370 |
Why?
| | Adult | 34 | 2025 | 35177 | 0.370 |
Why?
| | Parkinsonian Disorders | 1 | 2011 | 36 | 0.370 |
Why?
| | Hallucinogens | 2 | 2023 | 86 | 0.340 |
Why?
| | Narcotic Antagonists | 5 | 2025 | 160 | 0.340 |
Why?
| | Analgesics, Non-Narcotic | 3 | 2023 | 118 | 0.330 |
Why?
| | Male | 38 | 2025 | 62758 | 0.330 |
Why?
| | Pharmacovigilance | 3 | 2024 | 21 | 0.330 |
Why?
| | Female | 40 | 2025 | 68017 | 0.320 |
Why?
| | Adolescent | 23 | 2025 | 20158 | 0.310 |
Why?
| | Child | 23 | 2025 | 20636 | 0.300 |
Why?
| | Naloxone | 6 | 2025 | 110 | 0.290 |
Why?
| | Child, Preschool | 17 | 2025 | 10378 | 0.280 |
Why?
| | Aged | 18 | 2023 | 21892 | 0.280 |
Why?
| | Time Factors | 9 | 2025 | 6479 | 0.280 |
Why?
| | Suicide, Attempted | 3 | 2024 | 349 | 0.280 |
Why?
| | Cannabinoids | 2 | 2021 | 129 | 0.270 |
Why?
| | Substance-Related Disorders | 4 | 2020 | 1010 | 0.260 |
Why?
| | Treatment Outcome | 10 | 2020 | 10110 | 0.250 |
Why?
| | Cannabis | 2 | 2023 | 426 | 0.240 |
Why?
| | Intubation, Intratracheal | 2 | 2025 | 238 | 0.240 |
Why?
| | Infant | 13 | 2025 | 8912 | 0.240 |
Why?
| | Edema | 2 | 2023 | 120 | 0.240 |
Why?
| | Drug Contamination | 1 | 2024 | 51 | 0.230 |
Why?
| | Bupropion | 1 | 2024 | 40 | 0.230 |
Why?
| | Cohort Studies | 10 | 2024 | 5378 | 0.220 |
Why?
| | Plant Poisoning | 1 | 2023 | 9 | 0.220 |
Why?
| | Central Nervous System Stimulants | 1 | 2025 | 153 | 0.210 |
Why?
| | Substance Abuse Detection | 2 | 2021 | 73 | 0.210 |
Why?
| | Adenosine Monophosphate | 1 | 2024 | 62 | 0.210 |
Why?
| | Talc | 1 | 2023 | 7 | 0.210 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2023 | 28 | 0.210 |
Why?
| | Predictive Value of Tests | 4 | 2017 | 1934 | 0.210 |
Why?
| | Alanine | 1 | 2024 | 141 | 0.210 |
Why?
| | Multicenter Studies as Topic | 1 | 2024 | 285 | 0.210 |
Why?
| | Metals, Heavy | 2 | 2021 | 30 | 0.210 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2025 | 201 | 0.210 |
Why?
| | Prescription Drug Misuse | 2 | 2021 | 39 | 0.200 |
Why?
| | Opioid-Related Disorders | 2 | 2021 | 480 | 0.200 |
Why?
| | Psychotropic Drugs | 4 | 2023 | 67 | 0.200 |
Why?
| | Foodborne Diseases | 1 | 2023 | 48 | 0.200 |
Why?
| | Ivermectin | 1 | 2022 | 13 | 0.200 |
Why?
| | Methadone | 2 | 2020 | 89 | 0.200 |
Why?
| | Narcotics | 1 | 2022 | 45 | 0.190 |
Why?
| | Snakes | 2 | 2022 | 20 | 0.190 |
Why?
| | Larva | 1 | 2023 | 212 | 0.190 |
Why?
| | Vertigo | 1 | 2022 | 38 | 0.190 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 55 | 0.190 |
Why?
| | Sulfonylurea Compounds | 1 | 2022 | 46 | 0.190 |
Why?
| | Nausea | 1 | 2022 | 108 | 0.190 |
Why?
| | Tremor | 1 | 2022 | 60 | 0.190 |
Why?
| | Dizziness | 1 | 2022 | 79 | 0.190 |
Why?
| | Vomiting | 1 | 2022 | 126 | 0.180 |
Why?
| | Diarrhea | 1 | 2022 | 178 | 0.180 |
Why?
| | Research Personnel | 4 | 2022 | 156 | 0.180 |
Why?
| | Coral Snakes | 1 | 2020 | 3 | 0.180 |
Why?
| | Elapid Venoms | 1 | 2020 | 17 | 0.180 |
Why?
| | Abdominal Pain | 1 | 2022 | 144 | 0.180 |
Why?
| | Risk Factors | 7 | 2024 | 9696 | 0.170 |
Why?
| | Cocaine | 1 | 2022 | 148 | 0.170 |
Why?
| | Eating | 1 | 2023 | 368 | 0.170 |
Why?
| | Crotalus | 1 | 2020 | 26 | 0.170 |
Why?
| | Creatinine | 1 | 2022 | 478 | 0.170 |
Why?
| | Crotalid Venoms | 1 | 2020 | 31 | 0.170 |
Why?
| | Prevalence | 3 | 2024 | 2541 | 0.160 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 363 | 0.160 |
Why?
| | Antidepressive Agents | 3 | 2016 | 220 | 0.160 |
Why?
| | Heavy Metal Poisoning | 2 | 2021 | 3 | 0.160 |
Why?
| | Loperamide | 1 | 2018 | 10 | 0.160 |
Why?
| | Antidiarrheals | 1 | 2018 | 15 | 0.160 |
Why?
| | Annual Reports as Topic | 1 | 2018 | 3 | 0.150 |
Why?
| | Crime | 1 | 2019 | 56 | 0.150 |
Why?
| | Viperidae | 1 | 2018 | 7 | 0.150 |
Why?
| | Retrospective Studies | 6 | 2024 | 14404 | 0.150 |
Why?
| | Hospital Mortality | 4 | 2025 | 844 | 0.150 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2018 | 59 | 0.150 |
Why?
| | Israel | 2 | 2017 | 46 | 0.140 |
Why?
| | Aged, 80 and over | 7 | 2019 | 7029 | 0.140 |
Why?
| | Drug Misuse | 1 | 2017 | 1 | 0.140 |
Why?
| | London | 1 | 2017 | 45 | 0.140 |
Why?
| | Animals | 8 | 2023 | 34487 | 0.140 |
Why?
| | Crime Victims | 1 | 2019 | 111 | 0.140 |
Why?
| | Brain Death | 1 | 2017 | 46 | 0.130 |
Why?
| | Neurologic Examination | 1 | 2017 | 115 | 0.130 |
Why?
| | Prosthesis Failure | 1 | 2017 | 112 | 0.130 |
Why?
| | Designer Drugs | 1 | 2016 | 8 | 0.130 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2018 | 171 | 0.130 |
Why?
| | Biomarkers | 3 | 2017 | 3874 | 0.130 |
Why?
| | North America | 3 | 2022 | 289 | 0.120 |
Why?
| | Prognosis | 3 | 2020 | 3766 | 0.120 |
Why?
| | Hypnotics and Sedatives | 1 | 2016 | 156 | 0.120 |
Why?
| | Chronic Pain | 1 | 2019 | 253 | 0.120 |
Why?
| | Pregnancy | 3 | 2023 | 6355 | 0.120 |
Why?
| | Odds Ratio | 1 | 2017 | 1018 | 0.120 |
Why?
| | Hospitalization | 4 | 2022 | 2057 | 0.110 |
Why?
| | Length of Stay | 2 | 2025 | 1114 | 0.110 |
Why?
| | Body Burden | 1 | 2013 | 7 | 0.110 |
Why?
| | Tertiary Care Centers | 1 | 2015 | 146 | 0.110 |
Why?
| | Hydrofluoric Acid | 1 | 2013 | 8 | 0.110 |
Why?
| | Urinalysis | 1 | 2013 | 69 | 0.110 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3009 | 0.110 |
Why?
| | Unnecessary Procedures | 1 | 2013 | 48 | 0.110 |
Why?
| | Hypoglycemic Agents | 1 | 2022 | 1212 | 0.100 |
Why?
| | Poison Control Centers | 2 | 2015 | 89 | 0.100 |
Why?
| | International Cooperation | 1 | 2013 | 171 | 0.100 |
Why?
| | Alanine Transaminase | 2 | 2024 | 151 | 0.100 |
Why?
| | Australia | 1 | 2013 | 243 | 0.100 |
Why?
| | Data Mining | 1 | 2013 | 109 | 0.100 |
Why?
| | Canada | 1 | 2013 | 344 | 0.100 |
Why?
| | Organic Chemicals | 1 | 2013 | 128 | 0.100 |
Why?
| | Coma | 2 | 2023 | 32 | 0.100 |
Why?
| | Hospitals, Pediatric | 1 | 2015 | 505 | 0.090 |
Why?
| | Pediatrics | 2 | 2018 | 1044 | 0.090 |
Why?
| | Cooperative Behavior | 1 | 2013 | 424 | 0.090 |
Why?
| | Pregnancy Complications | 1 | 2015 | 487 | 0.090 |
Why?
| | Compensation and Redress | 1 | 2010 | 7 | 0.090 |
Why?
| | Consultants | 1 | 2010 | 13 | 0.080 |
Why?
| | Half-Life | 1 | 2010 | 149 | 0.080 |
Why?
| | Water | 1 | 2013 | 439 | 0.080 |
Why?
| | Injections, Intravenous | 1 | 2010 | 197 | 0.080 |
Why?
| | Blood Chemical Analysis | 1 | 2010 | 94 | 0.080 |
Why?
| | HIV Infections | 1 | 2024 | 2703 | 0.080 |
Why?
| | Societies, Medical | 1 | 2013 | 741 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2013 | 709 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2703 | 0.080 |
Why?
| | Clinical Trials as Topic | 1 | 2013 | 997 | 0.080 |
Why?
| | Seizures | 1 | 2012 | 400 | 0.080 |
Why?
| | Infant, Newborn | 3 | 2020 | 5688 | 0.080 |
Why?
| | Survivors | 1 | 2011 | 462 | 0.070 |
Why?
| | Databases, Factual | 3 | 2017 | 1264 | 0.070 |
Why?
| | Missouri | 1 | 2024 | 70 | 0.060 |
Why?
| | Pennsylvania | 1 | 2024 | 107 | 0.060 |
Why?
| | Outpatients | 2 | 2021 | 366 | 0.060 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2024 | 42 | 0.060 |
Why?
| | Health Personnel | 1 | 2010 | 645 | 0.050 |
Why?
| | Inpatients | 2 | 2021 | 464 | 0.050 |
Why?
| | Chromatography, Liquid | 1 | 2025 | 377 | 0.050 |
Why?
| | Xylazine | 1 | 2023 | 14 | 0.050 |
Why?
| | Piperidines | 1 | 2024 | 190 | 0.050 |
Why?
| | Risk Assessment | 3 | 2019 | 3223 | 0.050 |
Why?
| | Phenacetin | 1 | 2022 | 1 | 0.050 |
Why?
| | Alprazolam | 1 | 2022 | 6 | 0.050 |
Why?
| | Codeine | 1 | 2022 | 5 | 0.050 |
Why?
| | Lactic Acid | 1 | 2024 | 294 | 0.050 |
Why?
| | Bradycardia | 1 | 2023 | 53 | 0.050 |
Why?
| | Levamisole | 1 | 2022 | 19 | 0.050 |
Why?
| | Attitude of Health Personnel | 1 | 2010 | 1088 | 0.050 |
Why?
| | Age Factors | 2 | 2020 | 3100 | 0.050 |
Why?
| | Chloroquine | 1 | 2022 | 52 | 0.050 |
Why?
| | Heroin | 1 | 2022 | 30 | 0.050 |
Why?
| | United States Food and Drug Administration | 1 | 2023 | 197 | 0.050 |
Why?
| | Benzimidazoles | 1 | 2022 | 158 | 0.050 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2020 | 36 | 0.040 |
Why?
| | Paresthesia | 1 | 2020 | 9 | 0.040 |
Why?
| | Erythema | 1 | 2020 | 27 | 0.040 |
Why?
| | Anticonvulsants | 2 | 2012 | 199 | 0.040 |
Why?
| | Antiemetics | 1 | 2020 | 39 | 0.040 |
Why?
| | Texas | 1 | 2020 | 227 | 0.040 |
Why?
| | Emergency Treatment | 1 | 2021 | 113 | 0.040 |
Why?
| | Ethanol | 1 | 2023 | 585 | 0.040 |
Why?
| | Weapons of Mass Destruction | 1 | 2018 | 1 | 0.040 |
Why?
| | Atrioventricular Block | 1 | 2018 | 35 | 0.040 |
Why?
| | Antiviral Agents | 1 | 2024 | 710 | 0.040 |
Why?
| | Retreatment | 1 | 2017 | 69 | 0.040 |
Why?
| | Long QT Syndrome | 1 | 2018 | 67 | 0.040 |
Why?
| | Opiate Substitution Treatment | 1 | 2019 | 134 | 0.040 |
Why?
| | Demography | 1 | 2018 | 278 | 0.040 |
Why?
| | Critical Illness | 1 | 2023 | 755 | 0.040 |
Why?
| | Toxiferine | 1 | 2016 | 1 | 0.030 |
Why?
| | Respiratory Insufficiency | 1 | 2020 | 311 | 0.030 |
Why?
| | Societies, Scientific | 1 | 2016 | 45 | 0.030 |
Why?
| | Sentinel Surveillance | 1 | 2016 | 40 | 0.030 |
Why?
| | Pharmaceutical Preparations | 1 | 2018 | 168 | 0.030 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 314 | 0.030 |
Why?
| | Medicare | 1 | 2021 | 715 | 0.030 |
Why?
| | Patient Admission | 1 | 2017 | 182 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2598 | 0.030 |
Why?
| | Buprenorphine | 1 | 2019 | 160 | 0.030 |
Why?
| | Electrocardiography | 1 | 2018 | 607 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1473 | 0.030 |
Why?
| | Nonprescription Drugs | 1 | 2015 | 66 | 0.030 |
Why?
| | Pain | 1 | 2020 | 748 | 0.030 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2015 | 87 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4369 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 302 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2025 | 5034 | 0.030 |
Why?
| | Program Evaluation | 1 | 2017 | 872 | 0.030 |
Why?
| | Device Removal | 1 | 2013 | 134 | 0.020 |
Why?
| | Acute Disease | 1 | 2015 | 961 | 0.020 |
Why?
| | Oxycodone | 1 | 2012 | 42 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 1994 | 0.020 |
Why?
| | Acetylcysteine | 1 | 2012 | 141 | 0.020 |
Why?
| | Prosthesis Design | 1 | 2013 | 302 | 0.020 |
Why?
| | Health Promotion | 1 | 2017 | 716 | 0.020 |
Why?
| | Cardiovascular Agents | 1 | 2012 | 152 | 0.020 |
Why?
| | Antipsychotic Agents | 1 | 2012 | 192 | 0.020 |
Why?
| | Acetaminophen | 1 | 2012 | 245 | 0.020 |
Why?
| | Administration, Oral | 1 | 2012 | 766 | 0.020 |
Why?
| | Emergency Medical Services | 1 | 2015 | 518 | 0.020 |
Why?
| | Data Collection | 1 | 2011 | 645 | 0.020 |
Why?
| | Incidence | 1 | 2012 | 2614 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2010 | 5353 | 0.010 |
Why?
|
|
Brent's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|